How Long Does Fever Last After 2 Month Vaccinations?

Post-vaccination fever in two-month-old infants typically begins within six to twelve hours of the shots and resolves within one to two days. Most babies who develop a fever after their first round of routine immunizations see their temperature return to normal within 24 to 48 hours without any treatment. The fever itself is a sign the immune system is responding to the vaccines, and while it can be alarming for new parents, it is almost always harmless and self-limiting.

Why Vaccines Trigger a Fever

When a vaccine is injected, the immune system recognizes the introduced antigens as foreign and mounts a response. Part of that response involves releasing signaling molecules, including cytokines such as interleukin-1 and tumor necrosis factor alpha, which act on the brain’s temperature-regulation center and push body temperature upward.¹ This is the same basic process that produces a fever when your body fights off an actual infection. The difference is that vaccines contain inactivated or weakened components that cannot cause the disease itself, so the fever tends to be mild and brief compared with what a real infection would produce.

In two-month-olds, the immune system is still maturing, which means responses can vary quite a bit from one baby to another. Some infants spike a noticeable fever of around 38–38.5 °C (about 100.4–101.3 °F) within hours of their appointment, while others show no temperature change at all. Both responses are normal.

Which Vaccines at Two Months Are Most Likely to Cause Fever

At the two-month visit in most countries, infants receive several vaccines at once. The standard schedule in the United States includes a combination vaccine covering diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (often given as a single shot), along with pneumococcal conjugate vaccine, hepatitis B vaccine, and an oral rotavirus vaccine. In some countries, a meningococcal B vaccine is also given at this age.

The injectable vaccines, particularly the pertussis-containing combination and the pneumococcal conjugate, are the ones most associated with fever. These contain adjuvants designed to boost the immune response, which also makes a mild fever more likely. The oral rotavirus vaccine, by contrast, tends to be very well tolerated in terms of fever. Clinical trials of the live attenuated rotavirus vaccine found that fever rates were similar between vaccinated infants and those who received a placebo during the 15-day monitoring window after each dose.² Earlier safety testing of the same vaccine strain found it was essentially non-reactogenic in susceptible infants, with no temporal association between the vaccine and fever.³

Where a meningococcal B vaccine is co-administered at two months, fever rates tend to be higher than with the other routine vaccines alone. This is one reason some national schedules space out the meningococcal B dose from the rest, and why healthcare providers in those countries sometimes recommend having infant acetaminophen (paracetamol) on hand specifically for that visit.

The Typical Timeline

For the injectable vaccines given at two months, the pattern is fairly predictable. Fever usually appears within 6 to 12 hours after the shots, peaks somewhere around 12 to 24 hours, and fades by 48 hours. A minority of infants stay slightly warm for a third day, but by 72 hours the vast majority have fully recovered.

The oral rotavirus vaccine, if it causes any gastrointestinal symptoms at all, tends to show them a bit later, within the first week. But as noted, fever specifically is not a prominent feature of the rotavirus vaccine response.

If a fever first appears more than 48 hours after vaccination, clinicians treat that differently. A case series examining febrile infants who presented to emergency departments after meningococcal B immunization found that fever starting beyond the 48-hour mark was more likely to reflect an unrelated infection rather than a vaccine reaction, and the authors recommended extra caution in that scenario.⁴ This is a useful rule of thumb for parents: a fever in the first day or two after shots is almost certainly vaccine-related, but one that shows up on day three or later deserves a call to the pediatrician to rule out something else.

When Fever After Vaccination Needs Medical Attention

Most post-vaccination fevers are low-grade and do not require any medical evaluation. But two-month-olds are in an age group where fever is always taken seriously, vaccine day or not, because their immune defenses are still developing and serious bacterial infections can present subtly. This creates a real diagnostic challenge for emergency physicians: is a feverish eight-week-old sick from their vaccines or from a separate bacterial infection?

Research comparing infants with confirmed vaccine reactions to those with invasive bacterial infections found that clinical scoring systems can help tell them apart, but not perfectly. Infants with true bacterial infections were about five times more likely to be classified as “high risk” on standardized assessment tools compared to infants whose fever was a vaccine side effect.⁵ Still, about one in ten infants later diagnosed with a bacterial infection initially looked “low risk,” which is why physicians tend to err on the side of caution with young babies.

As a parent, you should seek medical evaluation if your two-month-old has:

Temperature at or above 38 °C (100.4 °F) rectally: In babies under three months, any fever at this threshold warrants a call to the doctor, even on vaccination day. Many infants with post-vaccine fever will cross this line, and most will be fine, but the pediatrician may want to evaluate or at least discuss the situation.
Fever lasting beyond 48 hours: As described above, fever that persists or newly appears after the two-day window is less likely to be vaccine-related.
Poor feeding, unusual lethargy, or inconsolable crying: These suggest the baby may not just be experiencing routine vaccine fussiness.
Any rash with petechiae (tiny non-blanching purple or red dots): This is not a typical vaccine reaction and could indicate something more serious.

Managing Post-Vaccination Fever

For a baby who is mildly warm but otherwise feeding well and behaving normally, no treatment is strictly necessary. Keeping the room comfortable, offering frequent feeds (breast milk or formula), and dressing the baby in light clothing are usually enough. Warm compresses applied to the injection site can help with local pain and swelling; a study of toddlers after immunization found that warm compresses were more effective at reducing discomfort than cold compresses.⁶

If the fever is making the baby uncomfortable, infant acetaminophen (paracetamol) is the standard option for babies two months and older, dosed by weight. Ibuprofen is not recommended for infants under six months. The key point here is that fever-reducing medication should be given in response to discomfort, not as a preventive measure before or immediately after the vaccines.

Why You Should Not Give Fever Medicine Before Vaccines

It used to be common advice for parents to give a dose of acetaminophen before or right after the vaccine appointment to “get ahead of” any fever. The evidence now argues against this. A randomized trial involving over 450 infants found that those given three prophylactic doses of paracetamol in the first 24 hours after vaccination had significantly lower antibody levels to multiple vaccine antigens compared with infants who received no prophylactic paracetamol. The effect persisted even after booster doses for several of the antigens measured.⁷ Fever rates did drop in the prophylactic group, but the trade-off was a weaker immune response to the vaccines themselves.

The clinical significance of this antibody reduction is still debated. A review of available evidence found that observational studies generally did not show antibody reductions with antipyretic use, but the few randomized trials that did look at it confirmed a measurable blunting effect.⁸ Whether the reduced antibody levels translate to any real reduction in protection is unknown, but given the uncertainty, the current consensus is straightforward: do not give fever medicine before the vaccines; wait to see if the baby actually becomes uncomfortable, and treat then.

Febrile Seizures and the Two-Month Vaccines

Febrile seizures are a specific parental fear, and understandably so. These are brief convulsions triggered by a rapid rise in body temperature, and they can happen in young children with any fever, whether from a virus or a vaccine. The good news is that febrile seizures are uncommon at two months of age. They are far more typical in children between six months and five years, when the developing brain is at its most susceptible to temperature-related seizure activity.

A large Danish study tracking children who received the combination diphtheria-tetanus-pertussis-polio-Hib vaccine found that the risk of febrile seizure was elevated on the day of the first and second vaccinations compared with a reference period, but the absolute numbers were very small: roughly 5 to 6 per 100,000 person-days for the first and second doses.⁹ By the day after vaccination, the elevated risk had already disappeared. The study also found no increased long-term risk of epilepsy after vaccination.

For parents of two-month-olds specifically, the take-home is that febrile seizures from the first vaccine dose are possible but rare, and even when they occur, they do not cause lasting harm and do not signal epilepsy. If your baby does have a seizure of any kind, call emergency services regardless of the suspected cause.

Special Considerations for Premature Infants

Premature babies generally receive their vaccines at the same chronological age as full-term babies, meaning they get their two-month shots at two months of actual age, not two months after their due date. This is standard practice because preterm infants are especially vulnerable to vaccine-preventable diseases. However, the post-vaccination period in premature infants may look a bit different.

A randomized trial of hospitalized preterm infants found that those who received their two-month vaccines were more likely to experience apnea (brief pauses in breathing) in the 48 hours afterward compared with a control group that had vaccination deferred. About 24% of vaccinated preterm infants had at least one apneic event during the monitoring period, compared with 10% in the unvaccinated group.¹⁰ No serious adverse events occurred in either group, but the finding explains why premature infants who are still in the hospital at vaccine time are typically monitored for 48 hours afterward.

For preterm infants who have already been discharged home, the fever timeline and management are the same as for term infants. The threshold for calling the pediatrician is lower, though, simply because premature babies have less physiologic reserve. If your premature baby develops any fever after vaccination, it is reasonable to contact your doctor even if the baby seems comfortable.

Co-Administration With Newer Preventive Treatments

In recent years, some infants receive nirsevimab, a monoclonal antibody against respiratory syncytial virus (RSV), around the same time as their routine two-month vaccines. Parents sometimes wonder whether stacking these together changes the side-effect profile. Pooled safety data from the pivotal clinical trials of nirsevimab found no additional safety signal when the antibody was co-administered with routine childhood vaccines in healthy term and preterm infants.¹¹ In other words, getting nirsevimab alongside the two-month vaccines does not appear to make fever or other reactions more likely or more severe than the vaccines alone would produce.

This matters practically because the RSV season may overlap with a baby’s two-month appointment, and parents should not feel they need to schedule separate visits or delay one treatment to avoid the other. The standard guidance is that both can be given at the same appointment.

What a Vaccine Fever Is Not

A common misconception is that a stronger fever means the vaccine is “working better” or, conversely, that no fever means the vaccine did not take. Neither is true. While fever does correlate with immune activation in a general sense, the absence of fever does not mean the immune system failed to respond. Antibody production happens regardless of whether the baby’s temperature rises enough for you to notice. Plenty of infants mount an excellent immune response with no visible symptoms at all.

Another misconception is that the fever means the baby is “getting a mild case” of the disease. With inactivated vaccines, which make up most of the two-month schedule, there is no live pathogen present and no possibility of infection. The rotavirus vaccine is live-attenuated, but as the clinical data show, it rarely causes fever. Symptoms from the rotavirus vaccine, if they appear at all, tend to be mild and gastrointestinal rather than febrile.

Finally, some parents worry that giving multiple vaccines at once overloads a baby’s immune system and causes worse side effects. Studies of combination and co-administered vaccines have not borne this out. Babies encounter far more antigens from a single common cold than from their entire two-month vaccine schedule. The fever response is driven by the adjuvanted injectable vaccines, and adding oral rotavirus or hepatitis B to the mix does not meaningfully change the fever profile.

Keeping a Record for Future Doses

If your baby had a noticeable fever after the two-month vaccines, it is worth noting the timing and peak temperature. The same vaccines are repeated at four months and six months, and knowing how your baby reacted previously helps you and your pediatrician plan ahead. Some babies react more to the second or third dose than the first, while others react less. The Danish febrile-seizure study mentioned earlier found that the day-of-vaccination risk for febrile seizure was actually lower after the third dose than after the first two, which suggests the pattern is not always one of escalating reactions.⁹

A record also helps if you ever need to visit an emergency department with a feverish baby in the days after vaccination. Being able to tell the triage nurse exactly which vaccines were given and when can help the medical team quickly contextualize the fever and decide how aggressively to investigate. As the research on differentiating vaccine reactions from bacterial infections makes clear, timing is one of the most important pieces of information clinicians use in that assessment.⁴

1
PLOS ONE. The Effect of Prophylactic Antipyretic Administration on Post-Vaccination Adverse Reactions and Antibody Response in Children: A Systematic Review
2
The Pediatric Infectious Disease Journal. Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine
3
PubMed. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants
4
PubMed. Fever after meningococcal B immunisation: A case series
5
PubMed Central. Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
6
International Journal of Health, Economics, and Social Sciences (IJHESS). Effectiveness of Warm and Cold Compresses on Pain Levels Among Toddlers After Immunization in Community Health Services
7
The Lancet. Effect of prophylactic paracetamol administration on simulant infant febrile reaction rates and vaccine responses and immunogenicity
8
PubMed Central. Effect of antipyretic analgesics on immune responses to vaccination
9
JAMA. Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b
10
JAMA Pediatrics. Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial
11
PubMed Central. Comprehensive Summary of Safety Data on Nirsevimab in Infants and Children from All Pivotal Randomized Clinical Trials